News | April 13, 2026
Unichem’s US arm recalls Buspirone tablets after stability test OOS result
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
It promises fewer injections for vision loss patients
Subscribe To Our Newsletter & Stay Updated
